Lorena Lupinacci Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

11/2023	Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
1/2023	Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
1/2022	Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
6/2021	Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting.
1/2020	Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP).
1/2020	Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.
11/2019	Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
1/2018	Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorena Lupinacci Research Topics

Disease

8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 01/2018
3	Neoplasms (Cancer) 01/2023 - 11/2019
1	Exanthema (Rash) 01/2022

Drug/Important Bio-Agent (IBA)

4	NivolumabIBA 01/2023 - 11/2019
3	B7-H1 AntigenIBA 01/2023 - 11/2019
3	IpilimumabIBA 01/2023 - 11/2019
2	durvalumabIBA 11/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 11/2023 - 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	CrizotinibIBA 01/2018

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
2	Immunotherapy 01/2023 - 01/2020
1	Radiotherapy 01/2022
1	Therapeutics 01/2022